Prognostic value of the HALP score in metastatic castration-resistant prostate cancer: an analysis combined with time to castration resistance
2024

HALP Score's Prognostic Value in Prostate Cancer

Sample size: 152 publication 10 minutes Evidence: high

Author Information

Author(s): Gökmen İvo, Demir Nazan, Peker Pınar, Özcan Erkan, Akgül Fahri, Bayrakçı İsmail, Divriklioğlu Didem, Erdoğan Bülent, Topaloğlu Sernaz, Hacıoğlu Muhammet Bekir

Primary Institution: Trakya University School of Medicine

Hypothesis

Can the combination of HALP score and time to castration resistance predict overall survival and progression-free survival in metastatic castration-resistant prostate cancer patients?

Conclusion

The study validated that a low HALP score and short time to castration resistance are significant unfavorable prognostic indicators for patients with metastatic castration-resistant prostate cancer.

Supporting Evidence

  • Patients with a low HALP score had a median overall survival of 19.8 months.
  • Patients with a high HALP score had a median overall survival of 33.3 months.
  • Short time to castration resistance was linked to worse overall survival.
  • Combining HALP score and time to castration resistance improved prognostic accuracy.

Takeaway

Doctors can use the HALP score and how quickly cancer becomes resistant to treatment to better understand how long patients with prostate cancer might live.

Methodology

The study analyzed 152 patients with metastatic prostate cancer, assessing the HALP score and time to castration resistance to predict overall survival and progression-free survival.

Potential Biases

Potential bias in patient selection due to the retrospective nature of the study.

Limitations

The study's retrospective design and single-center data limit the generalizability of the findings.

Participant Demographics

Median age of participants was 70 years, with a range of 53-82 years; 34.2% had an ECOG performance status of 0.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI 16.1-23.4 for low HALP score group; 95% CI 27.9-38.7 for high HALP score group.

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fonc.2024.1431629

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication